TT
Lv11
30 积分
2024-01-28 加入
-
人工智能在我国消化内镜领域的研究现状和展望
6小时前
求助中
-
Safety and efficacy of apatinib in combination with chemotherapy with or without immunotherapy versus chemotherapy alone as first-line treatment for advanced gastric cancer
6小时前
已完结
-
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
2个月前
已完结
-
[Chinese expert consensus on diagnosis and treatment of neurologic immune-related adverse events associated with immune checkpoint inhibitors (2022 edition)]
5个月前
已完结
-
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
5个月前
已完结
-
Standard for diagnosis and treatment of primary liver cancer (2022 edition)
5个月前
已关闭
-
A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and Immunotherapy
5个月前
已完结
-
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
5个月前
已完结
-
A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk
6个月前
已完结
-
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
7个月前
已完结